Maliheh Ghadiri

Dr. Maliheh Ghadiri

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Life Sciences
Verified
Journal Article
Closed access
DADania Akbik
Dania Akbik
MGMaliheh Ghadiri
Maliheh Ghadiri
WCWojciech Chrzanowski
Wojciech Chrzanowski
RRRamin Rohanizadeh
Ramin Rohanizadeh

11 March 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MGMaliheh Ghadiri
Maliheh Ghadiri
PYPaul Young
Paul Young
DTDaniela Traini
Daniela Traini
New therapeutic agents such as proteins, peptides, and nucleic acid-based agents are being developed every year, making it vital to find a non-invasive route such as nasal or pulmonary for their administration. However, a major concern for some of these newly developed therapeutic agents is their poor absorption. Therefore, absorption enhancers have been investigated to address this major administration problem. This paper describes the basic concepts of transmucosal administration of drugs, and in particular the use of the pulmonary or nasal routes for administration of drugs with poor absorption. Strategies for the exploitation of absorption enhancers for the improvement of pulmonary or nasal administration are discussed, including use of surfactants, cyclodextrins, protease inhibitors, and tight junction modulators, as well as application of carriers such as liposomes and nanoparticles.

26 March 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
MGMaliheh Ghadiri
Maliheh Ghadiri
WCW. Chrzanowski
W. Chrzanowski
RRRamin Rohanizadeh
Ramin Rohanizadeh
Different types of cationic clay minerals and their applications in various biological systems.

6 January 2020 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
JSJesus Shrestha
Jesus Shrestha
Sajad Razavi BazazSajad Razavi Bazaz
Sajad Razavi Bazaz
HEHamidreza Aboulkheyr Es
Hamidreza Aboulkheyr Es
DADania Yaghobian Azari
Dania Yaghobian Azari
BTBenjamin Thierry
Benjamin Thierry
MGMaliheh Ghadiri
Maliheh Ghadiri
Recently, organ-on-a-chip models, which are microfluidic devices that mimic the cellular architecture and physiological environment of an organ, have been developed and extensively investigated. The chips can be tailored to accommodate the disease conditions pertaining to many organs; and in the case of this review, the lung. Lung-on-a-chip models result in a more accurate reflection compared to conventional in vitro models. Pharmaceutical drug testing methods traditionally use animal models in order to evaluate pharmacological and toxicological responses to a new agent. However, these responses do not directly reflect human physiological responses. In this review, current and future applications of the lung-on-a-chip in the respiratory system will be discussed. Furthermore, the limitations of current conventional in vitro models used for respiratory disease modeling and drug development will be addressed. Highlights of additional translational aspects of the lung-on-a-chip will be discussed in order to demonstrate the importance of this subject for medical research.

11 December 2014 in Langmuir
Verified
Journal Article
Closed access
DHDorian A. H. Hanaor
Dorian A. H. Hanaor
MGMaliheh Ghadiri
Maliheh Ghadiri
WCWojciech Chrzanowski
Wojciech Chrzanowski
YGYixiang Gan
Yixiang Gan

1 December 2019 in Organs-on-a-Chip
Verified
Journal Article
Open access
JSJesus Shrestha
Jesus Shrestha
MGMaliheh Ghadiri
Maliheh Ghadiri
MSMelane Shanmugavel
Melane Shanmugavel
SBSajad Razavi Bazaz
Sajad Razavi Bazaz
SVSteven Vasilescu
Steven Vasilescu
MWMajid Ebrahimi Warkiani
Majid Ebrahimi Warkiani